Bibliographic Info
GuidelineWHO consolidated guidelines on drug-resistant tuberculosis treatment
Year of Publication2019
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended in favor
Strong
Certainty of evidence
Very low
Antiretroviral therapy is recommended for all patients with HIV and drug-resistant TB requiring second line antituberculosis drugs, irrespective of CD4 cell count, as early as possible (within the first 8 weeks) following initiation of antituberculosis treatment